Verification and unmasking of widely used human esophageal adenocarcinoma cell lines

Journal of the National Cancer Institute

Volumn 102, Issue 4, 2010, Pages 271-274

  Boonstra, Jurjen J ^a,b   Van Marion, Ronald ^a   Beer, David G ^c   Lin, Lin ^c   Chaves, Paula ^d   Ribeiro, Catarina ^d   Pereira, A Dias ^d   Roque, Lúcia ^d   Darnton, S Jane ^e   Altorki, Nasser K ^f   Schrump, David S ^g   Klimstra, David S ^h   Tang, Laura H ^h   Eshleman, James R ⁱ   Alvarez, Hector ⁱ   Shimada, Yutaka ^j   Van Dekken, Herman ^a   Tilanus, Hugo W ^b   Dinjens, Winand N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Grupo de Estudos de Esófago de Barrett Do IPOLFG   (Portugal)

^e BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF TOYAMA   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GRN 163L; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; RAF PROTEIN; SORAFENIB; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESEARCH; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CARCINOMA; ESOPHAGEAL ADENOCARCINOMA; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT TANDEM REPEAT;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BENZENESULFONATES; BIOMEDICAL RESEARCH; CARCINOMA; CARCINOMA, LARGE CELL; CELL LINE, TUMOR; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; DNA FINGERPRINTING; ESOPHAGEAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; NATIONAL INSTITUTES OF HEALTH (U.S.); OLIGOPEPTIDES; PROTEIN KINASE INHIBITORS; PYRIDINES; STOMACH NEOPLASMS; TANDEM REPEAT SEQUENCES; TELOMERASE; UNITED STATES;

EID: 77649247178     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp499     Document Type: Article

References (23)

1. Masters JR, Thomson JA, Daly-Burns B, et al. Short tandem repeat profling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA. 2001;98(14): 8012-8017.
2. Masters JR. Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol. 2000;1(3): 233-236.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2): 71-96.
4. Paulson TG, Reid BJ. Focus on Barrett's esophagus and esophageal adenocarcinoma. Cancer Cell. 2004;6(1):11-16.
5. Trauth BC, Klas C, Peters AM, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 1989;245(4915):301-305.
6. Altorki N, Schwartz GK, Blundell M, Davis BM, Kelsen DP, Albino AP. Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic pheno-type and invasion potential. Cancer. 1993;72(3): 649-657.
7. Kan T, Shimada Y, Sato F, et al. Gene expression profling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun. 2004;286(4):792-801.
8. Rockett JC, Larkin K, Darnton SJ, Morris AG, Matthews HR. Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br J Cancer. 1997;75(2):258-263.
9. Alvarez H, Koorstra JB, Hong SM, et al. Establishment and characterization of a bona fde Barrett esophagus-associated adenocarci-noma cell line. Cancer Biol Ther. 2008;7(11): 1753-1755.
10. de Both NJ, Wijnhoven BP, Sleddens HF, Tilanus HW, Dinjens WNM. Establishment of cell lines from adenocarcinomas of the esophagus and gastric cardia growing in vivo and in vitro. Virchows Arch. 2001;438(5): 451-456.
11. Boonstra JJ, van der Velden AW, Beerens EC, et al. Mistaken identity of widely used esoph-ageal adenocarcinoma cell line TE-7. Cancer Res. 2007;67(17):7996-8001.
12. Souza RF, Shewmake K, Terada LS, Spechler SJ. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology. 2002;122(2): 299-307.
13. Souza RF, Shewmake K, Pearson S, et al. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxyge-nase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol. 2004;287(4): G743-G748.
14. Jaiswal K, Tello V, Lopez-Guzman C, Nwariaku F, Anthony T, Sarosi GA Jr. Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line. Surgery. 2004;136(2): 160-168.
15. Morgan C, Alazawi W, Sirieix P, Freeman T, Coleman N, Fitzgerald R. In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocar-cinoma cell line. Am J Gastroenterol. 2004;99(2): 218-224.
16. Vona-Davis L, Frankenberry K, Cunningham C, et al. MAPK and PI3K inhibition reduces proliferation of Barrett's adenocarcinoma in vitro. J Surg Res. 2005;127(1):53-58.
17. Delgado JS, Mustaf R, Yee J, et al. Sorafenib triggers antiproliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells. Dig Dis Sci. 2008;53(12):3055-3064.
18. Keswani RN, Chumsangsri A, Mustaf R, Delgado J, Cohen EE, Bissonnette M. Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line. Dis Esophagus. 2008;21(6):514-521.
19. Shammas MA, Koley H, Beer DG, Li C, Goyal RK, Munshi NC. Growth arrest, apo-ptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telo merase inhibitor. Gastroenterology. 2004;126(5): 1337-1346.
20. Shammas M, Koley H, Batchu R, Bertheau R, Protopopov A, Munshi N, Goyal R. Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: Mechanism and therapeutic potential. Mol Cancer. 2005;4. doi: 10.1186/1476-4598-4-24. (Pubitemid 41460835)
21. Shammas MA, Qazi A, Batchu RB, et al. Telomere maintenance in laser capture micro-dissection-purifed Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo. Clin Cancer Res. 2008;14(15):4971-4980.
22. Nelson-Rees WA, Flandermeyer RR, Daniels DW. T-1 cells are HeLa and not of normal human kidney origin. Science. 1980;209(4457): 719-720.
23. Nelson-Rees WA, Daniels DW, Flandermeyer RR. Cross-contamination of cells in culture. Science. 1981;212(4493):446-452.